Experienced pharmaceutical and biologics development leader with a strong track record in late-stage development, analytical strategy, clinical supply, and technical operations across AbbVie’s Ludwigshafen site. Currently Senior Director, PDS&T Pharm Tech, responsible for pharmaceutical development and commercial product support for AbbVie’s synthetic marketed products, including formulation and process development, material science, tech transfers, site transfers, and troubleshooting across a global three-site team. Previously led Parenteral PDS&T Analytical LU, overseeing late-stage analytical development for biologics within the OneCMC operating model and a global analytical control strategy spanning AD operations, bioassay/characterization, method development, and compliance. Earlier roles included Director of Biologics Analytical R&D, Director of Clinical Supply Project Management, and leadership positions in formulation sciences and process development, with a consistent focus on building teams, establishing new capabilities, and improving execution from development through GMP manufacturing. Broad expertise across analytics, formulation, process, supply, and operations enables cross-functional problem-solving, faster delivery, and stronger end-to-end value creation for AbbVie.